Evidence map›Paper›PMID 29028970›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study.

Nicole Salazar-Austin, Jennifer Hoffmann, Silvia Cohn, Fildah Mashabela, Ziyaad Waja, Sanjay Lala, Christopher Hoffmann, Kelly E Dooley, Richard E Chaisson, Neil Martinson and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2024
    Article
  14. Article
  15. Review
  16. The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  17. Review
  18. Article
  19. Caring for Adolescents and Young Adults With Tuberculosis or at Risk of Tuberculosis: Consensus Statement From an International Expert Panel.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Nicole Salazar-AustinCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
Jennifer HoffmannCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
Silvia CohnCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
Fildah MashabelaPerinatal HIV Research Unit (PHRU), MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, NRF/DST Centre of Excellence in Biomedical TB Research, South Africa.
Ziyaad WajaPerinatal HIV Research Unit (PHRU), MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, NRF/DST Centre of Excellence in Biomedical TB Research, South Africa.
Sanjay LalaDepartment of Pediatrics and Child Health, Chris Hani Baragwanath Hospital and University of the Witwatersrand, Soweto, South Africa.
Christopher HoffmannCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
Kelly E DooleyCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
Richard E ChaissonCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
Neil MartinsonCenter for Tuberculosis Research and Departments of Medicine and Pediatrics, Baltimore, Maryland.
TSHEPISO Study Team
Perinatal HIV Research Unit · ZAJohns Hopkins University · USChris Hani Baragwanath Hospital · ZAJohns Hopkins Medicine · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Impact of TB on Outcome of HIV in Pregnant WomenR01HD064354 · NICHD · JOHNS HOPKINS UNIVERSITY · PI CHAISSON, RICHARD E. · 2010 to 2014
$3.0M
PK/PD Issues in the Use of New Therapies for the Treatment of TuberculosisK23AI080842 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DOOLEY, KELLY E. · 2009 to 2013
$670k
NIAID NIH HHS K23 AI080842NICHD NIH HHS R01 HD064354
6 · The paper itself

Abstract

Background: Before the wide availability of antiretroviral therapy (ART), tuberculosis and human immunodeficiency virus (HIV) disease among pregnant women resulted in poor maternal and neonatal outcomes, including high rates of mother-to-child transmission of both HIV and tuberculosis. We aimed to describe the impact of tuberculosis among HIV-infected mothers on obstetric and infant outcomes in a population with access to ART. Methods: In this prospective cohort study, we followed up HIV-infected pregnant women with or without tuberculosis disease from January 2011 through January 2014 in Soweto, South Africa. Two controls were enrolled for each case patient, matched by enrollment time, maternal age, gestational age, and planned delivery clinic and followed up for 12 months after delivery. Results: We recruited 80 case patients and 155 controls, resulting in 224 live-born infants. Infants of mothers with HIV infection and tuberculosis disease had a higher risk of low birth weight (20.8% vs 10.7%; P = .04), prolonged hospitalization at birth (51% vs 16%; P < .001), infant death (68 vs 7 deaths per 1000 births; P < .001), and tuberculosis disease (12% vs 0%; P < .001) despite appropriate maternal therapy and infant tuberculosis preventive therapy. HIV transmission was higher among these infants (4.1% vs 1.3%; P = .20), though this difference was not statistically significant. Obstetric outcomes in coinfected women were also poorer with higher risks of maternal hospitalization (25% vs 11%; P = .005) and preeclampsia (5.5% vs 0.7%; P = .03). Conclusions: Tuberculosis in HIV coinfected pregnant women remains a significant threat to the health of both mothers and infants. Improving tuberculosis prevention and early diagnosis among pregnant women is critical.

Indexed as

Infant MortalityAdolescentAdultAnti-HIV AgentsAntitubercular AgentsFemaleGestational AgeHIV-1HIV InfectionsHospitalizationHumansInfantInfant, Low Birth WeightInfant, NewbornInfectious Disease Transmission, VerticalMothersAnti-HIV AgentsAntitubercular AgentsZidovudine

Identifiers

PMID29028970
PMCPMC5849996
OpenAlexW2789602402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.